AKT1 and central nervous system cancer: Glioma has shown amplified levels of many FGFR molecules among which patients displaying poor responses showed increased FGFR1 that was not seen in chemotherapy‐responsive patients.37, 38 The various downstream signalling targets of this molecule such as PI3K/AKT have already been mentioned above.